Professional Documents
Culture Documents
Nursing Care Plan: JH Cerilles State College Western Mindanao State Univeristy
Nursing Care Plan: JH Cerilles State College Western Mindanao State Univeristy
in consortium with
Western Mindanao State Univeristy
West Capitol Road, Balangasan District, Pagadian City
Instruct patient or assist with active Increases blood flow to muscles and
and passive ROM exercises of affected bone to improve muscle tone,
and unaffected extremities. maintain joint mobility; prevent
contractures or atrophy and calcium
resorption from disuse
Collaboration:
Administer medication as prescribed For effective management of the
by the attending physician disease
JH CERILLES STATE COLLEGE
in consortium with
Western Mindanao State Univeristy
West Capitol Road, Balangasan District, Pagadian City
Collaboration:
Administer and teach the patient For the effective management of the
about the drugs that are prescribed by disease
the attending physician.
JH CERILLES STATE COLLEGE
in consortium with
Western Mindanao State Univeristy
West Capitol Road, Balangasan District, Pagadian City
DRUG STUDY
Generic Name, Prescribed Dosage, Mechanism of Indication Contraindication Adverse Reaction Nursing Responsibilities
Brand Name, Frequency, and Action
Classification Route of
Administration
alendronate, 10 mg, once daily Inhibits bone Treatment of Hypocalcemia, Overdose produces BASELINE ASSESSMENT
Fosamax, bone in the morning or 70 resorption via glucocorticoid-induced abnormalities of the hypocalcemia, Obtain baseline serum calcium,
resorption mg weekly, PO actions on osteoporosis in men and esophagus, inability to hypophosphatemia, phosphate, alkaline phosphatase.
inhibitor, osteoclasts or women with low bone stand or sit upright for at significant GI Hypocalcemia, vitamin D
osteoclast mineral density who are least 30 min, sensitivity to disturbances. deficiency must be corrected before
precursors. receiving at least 7.5 mg alendronate or other Esophageal irritation beginning therapy.
predniSONE (or bisphosphonates; oral occurs if not given Assess pt’s ability to remain
Therapeutic equivalent). Treatment solution or effervescent with 6–8 oz of plain upright for at least 30 minutes.
Effect: and prevention of tablet should not be used water or if pt lies down
Leads to indirect osteoporosis in males in pts at risk for within 30 min of INTERVENTION/EVALUATION
increase in bone and postmenopausal aspiration. administration. May Monitor chemistries (esp. serum
mineral density. women. Treatment of increase risk of calcium, phosphorus, alkaline
Paget’s Disease: Paget’s disease of the osteonecrosis of the phosphatase levels).
Inhibits bone bone in pts who are jaw
resorption, leading symptomatic, at risk for PATIENT/FAMILY TEACHING
to an indirect future complications, or Expected benefits occur only when
decrease in bone with alkaline medication is taken with full glass
formation, but phosphatase equal to or (6–8 oz) of plain water, first thing
in the morning and at least 30 min
bone has a more greater than 2 times
before first food, beverage, or
normal ULN.
medication of the day is taken. Any
architecture.
other beverage (mineral water,
orange juice, coffee) significantly
reduces absorption of medication.
Do not lie down for at least 30 min
after taking medication (potentiates
delivery to stomach, reducing risk
of esophageal irritation).
Report new swallowing difficulties,
pain when swallowing, chest pain,
new/worsening heartburn.
Consider weight-bearing exercises,
modify behavioral factors (e.g.,
cigarette smoking, alcohol
consumption).
Supplemental calcium and vitamin
D should be taken if dietary intake
inadequate
DRUG STUDY
Generic Name, Prescribed Dosage, Mechanism of Indication Contraindication Adverse Reaction Nursing Responsibilities
Brand Name, Frequency, and Action
Classification Route of
Administration
ibandronate, Adults, Elderly: Inhibits bone Treatment/prevention of Hypersensitivity to Upper respiratory BASELINE ASSESSMENT
Boniva, calcium 150 mg once resorption via osteoporosis in ibandronate, other infection occurs Hypocalcemia, vitamin D
regulator monthly, PO activity on postmenopausal women. bisphosphonates; oral occasionally. deficiency must be corrected before
osteoclasts. OFF-LABEL: tablets in pts unable to Overdose results in beginning therapy.
Adults, Elderly: Hypercalcemia of stand or sit upright hypocalcemia, Obtain laboratory baselines, esp.
3 mg, q3mos, IV Therapeutic malignancy; reduces for at least 60 min; pts hypophosphatemia, serum chemistries, renal function.
Effect: Reduces bone pain and skeletal with abnormalities significant GI Obtain results of bone density
rate of bone complications from of the esophagus that disturbances. study.
resorption, metastatic bone disease would delay emptying
resulting in due to breast cancer (e.g., stricture, achalasia), INTERVENTION/EVALUATION
indirect increased hypocalcemia Monitor electrolytes, esp. serum
bone mineral calcium, phosphate.
density. Monitor renal function tests.
PATIENT/FAMILY TEACHING
Expected benefits occur only when
medication is taken with full glass
(6–8 oz) of plain water, first thing
in the morning and at least 60 min
before first food, beverage,
medication of the day. Any other
beverage (mineral water, orange
juice, coffee) significantly reduces
absorption of medication.
Do not chew, crush, dissolve, or
divide tablets; swallow whole.